אינטרון A עט רב מנתי להזרקה 18 מיליון יחידות בינלאומיות ישראל - עברית - Ministry of Health

אינטרון a עט רב מנתי להזרקה 18 מיליון יחידות בינלאומיות

merck sharp & dohme israel ltd - interferon alfa 2b 18 miu/ml - solution for injection - interferon alfa-2b - chronic hepatitis b, chronic hepatitis c, hairy cell leukemia, chronic myelogenous leukemia, aids related kaposi`s sarcoma, malignant melanoma.treatment of metastatic or recurrent renal cell carcinoma non hodgkin`s lymphoma. treatment of high tumour burden follicular lymphoma as adjunct to apropriate combination induction chemotherapy such as a chop like regimen.

פאגאינטרון מזרק מוכן לשימוש 80 מק"ג ישראל - עברית - Ministry of Health

פאגאינטרון מזרק מוכן לשימוש 80 מק"ג

merck sharp & dohme israel ltd - peginterferon alfa 2b 80 mcg / 0.5 ml - powder for solution for injection - interferon alfa-2b - peg- intron is indicated for the treatment of adult patients with histologically proven chronic hepatitis c who have elevated transaminases without liver decompensation and who are positive for serum hcv-rna or anti-hcv including naive patients with clinically stable hiv coinfection. the best way to use peg- intron in this indication is in combination with ribavirin. this combination is indicated in naive patients including patients with clinically stable hiv co-infection and in patients who have failed previous treatment with interferon alpha (pegylated or nonpegylated ) and ribavirin combination therapy or interferon alpha monotherapy. interferon monotherapy including peg-intron is indicated mainly in case of intolerance or contraindication to ribavirin. please refer also to the ribavirin physician's insert when pegintron is to be used in combination with ribavirin.

אינטרון אי 10 מיליון י.ב. תמיסה להזרקה או לעירוי ישראל - עברית - Ministry of Health

אינטרון אי 10 מיליון י.ב. תמיסה להזרקה או לעירוי

merck sharp & dohme israel ltd - interferon alfa 2b 10 miu - solution for injection - interferon alfa-2b - - chronic hepatitis b. - chronic hepatitis c. - hairy cell leukaemia. - chronic myelogenous leukaemia. - multiple myeloma. - folicular lymphoma. - carcinoid tumour. - malignant melanoma.